CVAR - ETF AI Analysis

Top Page

Cultivar ETF (CVAR)

Rating:57Neutral

Price Target:―

CVAR’s rating suggests it is a middle-of-the-road ETF with a mix of strong and weaker holdings. High-quality names like Newmont Mining, Hershey, Core Laboratories, and Northwest Gas support the fund with solid financial health, positive trends, and generally constructive outlooks, while weaker positions such as Alexandria Real Estate and Albemarle, which face profitability and cash flow challenges, likely weigh on the overall assessment. The main risk is that some holdings show financial and technical pressure, which could add volatility and limit the fund’s upside.

Positive Factors

Solid Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Broad Sector Diversification

Holdings are spread across many sectors, including health care, consumer defensive, materials, technology, and others, which helps reduce reliance on any single industry.

Several Strong Top Holdings

A number of the largest positions, such as Albemarle, Newmont Mining, Barrick Mining, and Alexandria Equities, have delivered strong year-to-date performance that supports the fund’s returns.

Negative Factors

High Expense Ratio

The fund’s expense ratio is relatively high for an ETF, which can eat into long-term returns for investors.

Heavy U.S. Concentration

With the vast majority of assets invested in U.S. companies, the ETF offers limited geographic diversification and is heavily tied to the U.S. market.

Mixed Performance Among Top Holdings

Some key positions, such as MarketAxess Holdings and Healthcare Services, have shown weak year-to-date performance, which can drag on overall fund results.

CVAR vs. SPDR S&P 500 ETF (SPY)

AUM39.48M

RegionNorth America

Expense Ratio0.87%

Beta0.58

IssuerCultivar

Inception DateDec 21, 2021

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume662

30 Day Avg. Volume1,440

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

32.20

Price Target Upside― Downside

Rating ConsensusHold

Number of Analyst Covering84

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

CVAR Summary

The Cultivar ETF (CVAR) is a U.S.-focused fund that looks across the whole stock market for companies that appear cheap compared with their business strength. It doesn’t track a set index, but instead picks value-style stocks of all sizes, from large to small. The fund owns well-known names like Southwest Airlines and The Hershey Company, along with many others in health care, consumer goods, materials, and more. Someone might invest for broad diversification with a tilt toward undervalued stocks that could rebound over time. A key risk is that value stocks can stay out of favor for long periods, so the price can go up and down with market swings.

How much will it cost me?The Cultivar ETF (CVAR) has an expense ratio of 0.87%, which means you’ll pay $8.70 per year for every $1,000 invested. This expense ratio is higher than average because the fund is actively managed, focusing on identifying undervalued companies with strong fundamentals rather than simply tracking an index.

What would affect this ETF?The Cultivar ETF (CVAR) could benefit from a recovery in the U.S. economy, as value investing strategies often perform well during periods of market stability and growth. Positive trends in sectors like Health Care and Technology, which make up significant portions of the ETF, could also drive returns. However, rising interest rates or economic uncertainty might negatively impact some of its top holdings, such as real estate and energy companies, and broader market volatility could challenge its value-focused approach.

CVAR Top 10 Holdings

CVAR’s story is driven by a handful of value names trying to turn the corner. Materials and energy-linked plays like Albemarle and gold giants Newmont and Barrick have been rising, giving the fund a solid lift from the commodities side. Core Laboratories is another bright spot, adding momentum from the energy services space. On the flip side, MarketAxess has been lagging and acting like a small anchor on performance, while Southwest Airlines is recovering but still a bit bumpy. With a U.S.-only lineup and a tilt toward materials, energy, and defensives, this ETF is clearly betting on overlooked value rather than flashy growth.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
MKTX	Marketaxess Holdings	4.03%	$1.61M	$6.67B	-7.30%	68 Neutral
CLB	Core Laboratories	3.28%	$1.31M	$864.22M	3.34%	72 Outperform
HCSG	Healthcare Services	2.46%	$981.76K	$1.52B	99.17%	72 Outperform
ARE	Alexandria Equities	2.15%	$860.68K	$9.10B	-44.66%	47 Neutral
LUV	Southwest Airlines	2.15%	$859.06K	$25.11B	68.79%	66 Neutral
NWN	Northwest Gas	2.13%	$851.37K	$2.09B	23.89%	73 Outperform
B	Barrick Mining	2.03%	$809.15K	$80.36B	167.06%	―
ALB	Albemarle	1.94%	$775.52K	$19.60B	104.84%	58 Neutral
PRLB	Proto Labs	1.91%	$763.65K	$1.60B	52.83%	70 Outperform
NEM	Newmont Mining	1.87%	$746.75K	$137.28B	170.30%	81 Outperform

CVAR Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

29.00

Positive

100DMA

28.30

Positive

200DMA

27.25

Positive

Market Momentum

MACD

0.21

Negative

RSI

60.32

Neutral

STOCH

83.01

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CVAR, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 29.54, equal to the 50-day MA of 29.00, and equal to the 200-day MA of 27.25, indicating a bullish trend. The MACD of 0.21 indicates Negative momentum. The RSI at 60.32 is Neutral, neither overbought nor oversold. The STOCH value of 83.01 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CVAR.

CVAR Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
CVAR	―	―	$39.48M	0.87%	―
BAMV	―	―	$98.01M	0.91%	―
TCV	―	―	$92.72M	0.85%	―
GMOV	―	―	$76.83M	0.50%	―
VUSV	―	―	$53.71M	0.30%	―
GVLE	―	―	$42.90M	0.45%	―

Performance Comparison

CVAR

Cultivar ETF

29.94

4.50

17.69%

BAMV

Brookstone Value Stock ETF

―

TCV

Towle Value ETF

―

GMOV

GMO US Value ETF

―

VUSV

Vanguard Wellington U.S. Value Active ETF

―

GVLE

Goldman Sachs Value Opportunities ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents